Pulsed ultrasounds accelerate healing of rib fractures in an experimental animal model: An effective new thoracic therapy?  Norberto Santana-Rodríguez,

Slides:



Advertisements
Similar presentations
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Advertisements

Manuel J. Antunes, MD, PhD, DSc 
One-lung ventilation: For how long?
Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell.
Expanding options to manage traumatic thoracic vascular injuries
Carbon monoxide reduces pulmonary ischemia–reperfusion injury in miniature swine  Hisashi Sahara, MD, Akira Shimizu, MD, PhD, Kentaro Setoyama, DVM, PhD,
Ultrasound, endoscopy, and the recurrent nerve
Ozone Therapy Protects Against Rejection in a Lung Transplantation Model: A New Treatment?  Norberto Santana-Rodríguez, MD, PhD, Pedro Llontop, PhD, Bernardino.
The days of future past  Neel K. Ranganath, MD, Aubrey C. Galloway, MD 
Intrinsic cardiac stem cells are essential for regeneration
Centers for Disease Control “increased-risk” organ donor: Not so risky?  Francis D. Pagani, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Abracadabra I, II…HeartMate 3?
Transcervical bedside brachiocephalic trunk clamping as a technique to reduce exsanguination from injuries to the upper right torso  David Perez, MD,
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
How should we treat air leaks?
New treatment approaches create new disease processes: A short guide on how to reduce unexpected events to a minimum  Martin Czerny, MD, MBA  The Journal.
Single-dose rosuvastatin ameliorates lung ischemia–reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage.
Improvement of cardiac function in the failing rat heart after transfer of skeletal myoblasts engineered to overexpress placental growth factor  Matthias.
The lord of the rings  Antonio Miceli, MD, PhD 
Aldo R. Castañeda, MD, PhD: Recipient of the Lifetime Achievement Award and 74th president of The American Association for Thoracic Surgery  Pedro J.
Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis  Masayuki Kubo, PhD, Tao-Sheng Li, MD, PhD, Takahiro.
The variability of the mitral valve anatomy and terminology
The tissue-engineered vascular graft using bone marrow without culture
Support Your Specialty
Benjamin G. Arenson, BSc, Lindsey A. MacDonald, BSc, Hilary P
Innovation and science: The future of valve design
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
Military surgeons just want to have fun
A first start for lung transplantation?
The Journal of Thoracic and Cardiovascular Surgery
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Michael Lanuti, MD  The Journal of Thoracic and Cardiovascular Surgery 
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
Uma M. Sachdeva, MD, PhD, Daniela Molena, MD 
Commentary: Do the right thing! Ethical versus legal
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
One-lung ventilation: For how long?
Functional tricuspid pathology: To treat or not to treat
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Cor triatriatum dexter: More than a simple membrane
Lung cancer lymph node micrometastasis detection using real-time polymerase chain reaction: Correlation with vascular endothelial growth factor expression 
First nights, the adrenal axis, and steroids
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Ralph E. Delius, MD  The Journal of Thoracic and Cardiovascular Surgery 
After neoadjuvant chemoradiation therapy, predicted pulmonary function may be reduced by 10%  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular.
“The more things change…”: The challenges ahead
Commentary: Judgment day: Should you add atrial fibrillation ablation?
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Aritoshi Hattori, MD, Kenji Suzuki, MD 
Apples remain apples NO matter what
Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery  Raja M. Flores, MD  The Journal.
Preoperative PFTs: The answer is blowing in the wind
Sunjay Kaushal, MD, PhD, Brody Wehman, MD 
Lucas G. Fernandez, MD, DSc, Timothy D
Did you like Terminator 3 better than Terminator 2
Samuel Kim, MD  The Journal of Thoracic and Cardiovascular Surgery 
Journal changes and initiatives
Akiko Tanaka, MD, PhD, Takeyoshi Ota, MD, PhD 
Deciding how much to pay for effective care
Presentation transcript:

Pulsed ultrasounds accelerate healing of rib fractures in an experimental animal model: An effective new thoracic therapy?  Norberto Santana-Rodríguez, MD, PhD, Bernardino Clavo, MD, PhD, Leandro Fernández-Pérez, MD, PhD, José C. Rivero, MD, María M. Travieso, MD, María D. Fiuza, MD, PhD, Jesús Villar, MD, PhD, José M. García-Castellano, MD, PhD, Octavio Hernández-Pérez, BSc, PhD, Antonio Déniz, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 141, Issue 5, Pages 1253-1258 (May 2011) DOI: 10.1016/j.jtcvs.2010.06.028 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Radiologic and histologic findings after pulsed ultrasound treatment of rib fractures. A, No radiologic callus (arrow) was observed in 1 representative control animal at 28 days of treatment. B, Radiologic bone callus (arrow) and periosteal reaction in 1 representative animal treated with 50 mW/cm2 at 28 days. C, Inflammatory infiltrate (arrow) and hemorrhage in 1 representative control animal at 28 days (original magnification 10×). D, Bone remodeling in 1 representative animal treated with 50 mW/cm2 where osteoclast cells (arrow) can be observed at 28 days (original magnification 40×). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1253-1258DOI: (10.1016/j.jtcvs.2010.06.028) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Histologic and radiologic bone consolidation with different doses of PUS. A, Histologic examination revealed that bone consolidation was higher in the pooled PUS treatment group than in the control group (66% vs 26.3%; P = .001). Consolidation at different doses of PUS was better than in the control groups (P = .003 for each doses subgroup), although this improvement was lower with 250 mW/cm2 than with lower doses (50 and 100 mW/cm2 ISATA; P = .027). B, Radiologic analysis revealed that incipient or formed bone callus was higher in the pooled PUS treatment group than in the control group (59.6% vs 26.3%; P = .001). Consolidation at different doses of PUS was better than in control group (P = .003 for each doses subgroup), although this improvement was lower with 250 mW/cm2 than with lower doses (50 and 100 mW/cm2 ISATA; P = .027). PUS, Pulsed ultrasound; ISATA, spatial average–temporal average intensity. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1253-1258DOI: (10.1016/j.jtcvs.2010.06.028) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Messenger RNA expression of IGF1, VEGF, SOCS2, and SOCS3. A, At 10 days, treatment with 100 mW/cm2 increased IGF1 (P = .004) and treatment with 250 mW/cm2 increased SOCS3 (P = .046), SOCS2 (P = .045), IGF1 (P = .003), and VEGFa (P = .032). No significant variations were observed with 50 mW/cm2 after 10 days of treatment. Data are representative of 3 independent experiments and error bars indicate standard deviations from the mean. ∗Statistically significantly differences between control and PUS treatment groups. B, At 28 days, animals treated with 100 mW/cm2 ISATA group had significantly higher levels of IGF1 (P = .006) and SOCS2 (P = .018). Animals treated with 250 mW/cm2 showed an increase of SOCS2 (P = .045), IGF1 (P = .006), and VEGFa (P = .028). No significant variations were observed with 50 mW/cm2 after 28 days of treatment. Data are representative of 3 independent experiments. Error bars indicate standard deviations from the mean. ∗Statistically significantly differences between control and PUS treatment group. PUS, Pulsed ultrasound; ISATA, spatial average–temporal average intensity; IGF1, insulin-like growth factor 1; VEGF, vascular endothelial growth factor; SOCS, suppressor of cytokine signaling. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 1253-1258DOI: (10.1016/j.jtcvs.2010.06.028) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions